Mutagenicity of New Lead Compounds to Treat Sickle Cell Disease Symptoms in a Salmonella/Microsome Assay
A series of phthalimide derivatives planned as drugs candidates to treat the symptoms of sickle cell anemia were evaluated in a mutagenicity test using strains of Salmonella typhimurium TA100 and TA102, without and with addition of S9 mixture, with the aim to identify the best structural requirement...
Main Authors: | Chung Man Chin, Lídia Moreira Lima, Eliana A. Varanda, Jean Leandro dos Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/11/2/779/ |
Similar Items
-
Evaluation of Betulin Mutagenicity by Salmonella/Microsome Test
by: Edson Hideaki Yoshida, et al.
Published: (2016-09-01) -
Mutagenicity and antimutagenicity of (−)-hinokinin a trypanosomicidal compound measured by <it>Salmonella</it> microsome and comet assays
by: Resende Flávia Aparecida, et al.
Published: (2012-10-01) -
Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease
by: Man Chin Chung, et al.
Published: (2011-04-01) -
Mutagenicity of Flavonoids Assayed by Bacterial Reverse Mutation (Ames) Test
by: Eliana Aparecida Varanda, et al.
Published: (2012-05-01) -
AN INVESTIGATION OF MUTAGENIC ACTIVITIES OF SOME 9- SUBSTITUEDPHENANTHRENE DERIVATIVES WITH AMES / SALMONELLA / MICROSOME TEST
by: Mehtap KUTLU, et al.
Published: (2011-02-01)